Valuation: AroCell AB

Market Cap 89.38M 9.01M 7.91M 7.47M 6.81M 12.74M 864M 12.83M 34.62M 441M 33.84M 33.11M 1.42B P/E 2024
-2.12x
P/E 2025 -6.69x
Enterprise Value 66.04M 6.66M 5.84M 5.52M 5.03M 9.41M 638M 9.48M 25.58M 326M 25M 24.46M 1.05B EV / Sales 2024
0.73x
EV / Sales 2025 1.09x
Free-Float
68.85%
Yield 2024 *
-
Yield 2025 -
1 day-1.52%
1 week-1.77%
Current month-1.52%
1 month-6.05%
3 months-9.35%
6 months+21.25%
Current year+9.92%
1 week 0.37
Extreme 0.373
0.4
1 month 0.37
Extreme 0.373
0.45
Current year 0.25
Extreme 0.25
0.53
1 year 0.25
Extreme 0.25
0.53
3 years 0.25
Extreme 0.25
0.66
5 years 0.25
Extreme 0.25
2.4
10 years 0.25
Extreme 0.25
8.45
Manager TitleAgeSince
Chief Executive Officer - 28/05/2026
Director of Finance/CFO - 18/08/2022
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 56 01/01/2020
Chairman 39 22/05/2024
Director/Board Member 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
02/09/21 Buy

Executive/Senior Manager

25,000 0.0220%
02/09/21 Buy 20,000 0.0176%
01/09/21 Buy

Director

5,353 0.0047%
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%-1.77%-3.72%-23.62% 9.01M
-0.14%+4.33%+9.88%+31.73% 47.97B
-1.69%+1.48%+53.02%+33.59% 44.5B
+2.56%+7.34%+382.17%+594.81% 43.93B
+0.24%+2.85%+9.78%+89.54% 41.03B
-0.62%-1.11%+4.70%+46.02% 29.85B
-0.28%+1.07%+26.83%+152.91% 17.27B
-0.46%+1.20%+26.78%+41.32% 15.3B
-2.21%-4.70% - - 14.82B
+3.37%+9.21%+9.93% - 15.34B
Average -0.08%+1.94%+57.71%+120.79% 27B
Weighted average by Cap. +0.11%+2.86%+83.03%+156.21%

Financials

2024 2025
Net sales 57.44M 5.79M 5.08M 4.8M 4.37M 8.19M 555M 8.25M 22.25M 284M 21.74M 21.27M 911M 53.11M 5.36M 4.7M 4.44M 4.04M 7.57M 513M 7.63M 20.57M 262M 20.11M 19.67M 843M
Net income -42.45M -4.28M -3.76M -3.55M -3.23M -6.05M -410M -6.09M -16.44M -210M -16.07M -15.72M -674M -12.15M -1.23M -1.08M -1.02M -925K -1.73M -117M -1.74M -4.71M -59.99M -4.6M -4.5M -193M
Net Debt -47.78M -4.82M -4.23M -3.99M -3.64M -6.81M -462M -6.86M -18.51M -236M -18.09M -17.7M -758M -23.34M -2.35M -2.06M -1.95M -1.78M -3.33M -226M -3.35M -9.04M -115M -8.84M -8.64M -370M
Logo AroCell AB
IDL Diagnostics AB (publ), formerly AroCell AB (publ), is a Sweden-based diagnostic Company engaged in the biotechnology and medical diagnostics industry. The Company focuses on research, development, manufacturing, and commercialization of diagnostic and medical technology products. The Company has a broad product portfolio of In Vitro Diagnostics (IVD) tests that deliver clinical information for the detection of disease with indications spanning everything from urological cancers to typhoid fever. IDL Diagnostics AB (publ) develops tests that are clinically useful and economically viable. The Company provides rapid tests, laboratory tests and platform tests that improve decision making and are non-invasive, cost effective, as well as easy to perform.
Employees
25
Date Price Change Volume
25/09/26 SEK 0.3880 -1.52% 44,027
24/09/26 SEK 0.3940 +4.79% 17,668
23/09/26 SEK 0.3760 -3.34% 16,766
22/09/26 SEK 0.3890 +4.01% 171,026
21/09/26 SEK 0.3740 -5.32% 404,902

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IDLDX Stock